Genetic Technologies (ASX:GTG)
ASX announcement history & article coverage
Transparent by design.
Announcments by Genetic Technologies (ASX:GTG) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
FY26 Appendix 4G & Corporate Governance Statement
FY26 Annual Report
Genetic Technologies reports net liabilities and going concern uncertainty while pursuing CST Diagnostics acquisition and ASX re-compliance
Half Yearly Report and Accounts December 2025
Genetic Technologies reports no revenue, net liabilities and material going concern uncertainty
Quarterly Activities/Appendix 4C Cash Flow Report June 2026
Genetic Technologies reports $10,000 cash balance amid minimal activity under DOCA
Quarterly Activities/Appendix 4C Cash Flow Report March 2026
Genetic Technologies reports $10,000 cash balance while operating under DOCA
Quarterly Activities/Appendix 4C Cash Flow Report Dec 2025
Genetic Technologies reports $10,000 cash balance and minimal quarterly activity under DOCA
FY25 Appendix 4G & Corporate Governance Statement
FY25 Appendix 4E & Annual Report
Genetic Technologies reports reduced loss and exit from administration after DOCA
